152 related articles for article (PubMed ID: 2874618)
1. The use of somatostatin and its analogs in the treatment of surgical disorders.
Mulvihill S; Pappas TN; Passaro E; Debas HT
Surgery; 1986 Sep; 100(3):467-76. PubMed ID: 2874618
[TBL] [Abstract][Full Text] [Related]
2. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
Feu F; Bosch J
Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
[No Abstract] [Full Text] [Related]
3. [Somatostatin in gastroenterological therapy].
Stalder GA; Kayasseh L; Gyr K
Schweiz Med Wochenschr Suppl; 1985; 19():30-6. PubMed ID: 2865809
[TBL] [Abstract][Full Text] [Related]
4. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
Gorden P; Comi RJ; Maton PN; Go VL
Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract.
Lamers CB
Acta Endocrinol Suppl (Copenh); 1987; 286():19-25. PubMed ID: 2892334
[TBL] [Abstract][Full Text] [Related]
6. [Use of somatostatin in gastroenterology].
Lamers CB
Ned Tijdschr Geneeskd; 1986 May; 130(20):908-11. PubMed ID: 2873515
[No Abstract] [Full Text] [Related]
7. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
Meier R; Dierdorf R; Gyr K
Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
[TBL] [Abstract][Full Text] [Related]
8. Potential indications for octreotide in gastroenterology: summary of workshop.
Burroughs AK; Malagelada R
Digestion; 1993; 54 Suppl 1():59-67. PubMed ID: 8359570
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.
de Herder WW; Lamberts SW
Endocrine; 2003 Apr; 20(3):285-90. PubMed ID: 12721509
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin for upper gastrointestinal hemorrhage and pancreatic surgery. A review of its pharmacology and safety.
Scarpignato C; Pelosini I
Digestion; 1999; 60 Suppl 3():1-16. PubMed ID: 10567784
[TBL] [Abstract][Full Text] [Related]
11. [Is there a sensible use for somatostatin in gastroenterology?].
Arnold R
Internist (Berl); 1986 Nov; 27(11):697-703. PubMed ID: 2879810
[No Abstract] [Full Text] [Related]
12. Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin).
Lamberts SW
Acta Endocrinol Suppl (Copenh); 1986; 276():41-55. PubMed ID: 2875590
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.
Wood SM; Kraenzlin ME; Adrian TE; Bloom SR
Gut; 1985 May; 26(5):438-44. PubMed ID: 2860052
[TBL] [Abstract][Full Text] [Related]
14. [Theoretical and physiopharmacological bases of the somatostatin treatment in digestive diseases].
Consolo F; Pustorino S
Minerva Chir; 1992 Apr; 47(8):723-9. PubMed ID: 1351277
[No Abstract] [Full Text] [Related]
15. [Somatostatin in the medical treatment of fistula of the pancreas and the small intestine].
Hild P; Stoyanov M; Dobroschke J; Aigner K
Sem Hop; 1982 Oct; 58(38):2195-8. PubMed ID: 6129704
[TBL] [Abstract][Full Text] [Related]
16. Future medical prospects for Sandostatin.
Harris AG
Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin in the treatment of gastrointestinal diseases in children.
Socha J; Rasiński A; Barra E; Cichy W; Celińska-Cedro D; Rondio H
Mater Med Pol; 1988; 20(1):6-11. PubMed ID: 2906107
[No Abstract] [Full Text] [Related]
18. Somatostatin and the gastrointestinal tract.
Tulassay Z
Scand J Gastroenterol Suppl; 1998; 228():115-21. PubMed ID: 9867121
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin and its analogs in the short bowel syndrome.
Rosen GH
Nutr Clin Pract; 1992 Apr; 7(2):81-5. PubMed ID: 1363486
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of new potential therapeutic applications of somatostatin analogs.
Pawlikowski M; Melen-Mucha G
Neuro Endocrinol Lett; 2003; 24(1-2):21-7. PubMed ID: 12743527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
